ES2051872T3 - Nuevo derivado de d.25, procedimiento de preparacion, utilizacion a titulo de agente inmunoestimulante y composiciones farmaceuticas que lo contienen. - Google Patents

Nuevo derivado de d.25, procedimiento de preparacion, utilizacion a titulo de agente inmunoestimulante y composiciones farmaceuticas que lo contienen.

Info

Publication number
ES2051872T3
ES2051872T3 ES88400963T ES88400963T ES2051872T3 ES 2051872 T3 ES2051872 T3 ES 2051872T3 ES 88400963 T ES88400963 T ES 88400963T ES 88400963 T ES88400963 T ES 88400963T ES 2051872 T3 ES2051872 T3 ES 2051872T3
Authority
ES
Spain
Prior art keywords
immuno
contain
pharmaceutical compositions
preparation procedure
stimulating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88400963T
Other languages
English (en)
Inventor
D Hinterland Lucien Dussourd
Gerard Normier
Anne-Marie Pinel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of ES2051872T3 publication Critical patent/ES2051872T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN DERIVADO POLISACARIDICO CARACTERIZADO PORQUE SE TRATA DE UN DERIVADO D 25 EN EL QUE LOS RESIDUOS GALACTOFURANOSA (GALF) DE LA CADENA POLISACARIDICA LINEAL HAN SIDO TRANSFORMADOS, AL MENOS EN PARTE, EN ARABINOSA. SE REFIERE TAMBIEN A SU PROCEDIMIENTO DE PREPARACION, SU USO A TITULO DE AGENTE INMUNOESTIMULANTE Y DE COMPOSICIONES FARMACEUTICAS QUE LO CONTIENEN.
ES88400963T 1987-04-22 1988-04-20 Nuevo derivado de d.25, procedimiento de preparacion, utilizacion a titulo de agente inmunoestimulante y composiciones farmaceuticas que lo contienen. Expired - Lifetime ES2051872T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705690A FR2614306B1 (fr) 1987-04-22 1987-04-22 Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.

Publications (1)

Publication Number Publication Date
ES2051872T3 true ES2051872T3 (es) 1994-07-01

Family

ID=9350369

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88400963T Expired - Lifetime ES2051872T3 (es) 1987-04-22 1988-04-20 Nuevo derivado de d.25, procedimiento de preparacion, utilizacion a titulo de agente inmunoestimulante y composiciones farmaceuticas que lo contienen.

Country Status (11)

Country Link
US (1) US4937327A (es)
EP (1) EP0288382B1 (es)
JP (1) JPH0192201A (es)
AT (1) ATE78833T1 (es)
AU (1) AU616403B2 (es)
CA (1) CA1312328C (es)
DE (1) DE3873139T2 (es)
ES (1) ES2051872T3 (es)
FR (1) FR2614306B1 (es)
GR (1) GR3005823T3 (es)
ZA (1) ZA882762B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2644059B1 (fr) * 1989-03-08 1994-03-04 Fabre Medicament Pierre Compositions aerosols destinees a l'imagerie, au diagnostic et a la therapie ciblee de foyers inflammatoires et tumoraux
FR2659351B1 (fr) * 1990-03-08 1994-12-02 Pf Medicament Compose polysaccharidique delipide, procede de preparation, compositions en comprenant.
US6444210B1 (en) * 1996-07-03 2002-09-03 Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence of Her Majesty′s Canadian Goverment Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL122086B1 (en) * 1979-04-09 1982-06-30 Politechnika Gdanska Process for preparing amides of antibiotics from the group of polyene macrolides and their derivativesvykh makrolidov i ikh proizvodnykh
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4716223A (en) * 1981-08-04 1987-12-29 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4593091A (en) * 1981-08-04 1986-06-03 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
JPS59124901A (ja) * 1982-12-29 1984-07-19 Dai Ichi Seiyaku Co Ltd 多糖誘導体
JPS60181020A (ja) * 1984-02-27 1985-09-14 Snow Brand Milk Prod Co Ltd 高粘性多糖体を有効成分とする抗腫瘍剤
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
FR2570081B1 (fr) * 1984-09-10 1987-01-09 Pf Medicament Polysaccharides membranaires utiles notamment comme medicament et procede pour leur preparation
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4755381A (en) * 1986-03-27 1988-07-05 Swiss Serum And Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
FR2598434B1 (fr) * 1986-05-12 1988-09-16 Pf Medicament Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
FR2620130B1 (fr) * 1987-09-08 1990-01-12 Lipha Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant

Also Published As

Publication number Publication date
US4937327A (en) 1990-06-26
ATE78833T1 (de) 1992-08-15
GR3005823T3 (es) 1993-06-07
JPH0192201A (ja) 1989-04-11
EP0288382B1 (fr) 1992-07-29
ZA882762B (en) 1988-10-21
FR2614306B1 (fr) 1989-07-28
AU616403B2 (en) 1991-10-31
CA1312328C (fr) 1993-01-05
EP0288382A3 (en) 1989-02-22
FR2614306A1 (fr) 1988-10-28
DE3873139D1 (de) 1992-09-03
DE3873139T2 (de) 1993-01-28
EP0288382A2 (fr) 1988-10-26
AU1523388A (en) 1988-10-27

Similar Documents

Publication Publication Date Title
DK588487A (da) Forbedrede metalholdige farmaceutiske midler
NZ233784A (en) Pharmaceutical composition comprising an inclusion compound of imipramine or derivative in cyclodextrin
BR8706704A (pt) Agente modificador de impacto para utilizacao com artigos de fumar
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
AU563650B2 (en) Pharmaceutical compositions of benzothiophene derivatives
BR9201253A (pt) Composto,processo para a sua preparacao,agente diagnostico ou terapeutico e aplicacao do mencionado composto
FR2651435B1 (es)
ES2051872T3 (es) Nuevo derivado de d.25, procedimiento de preparacion, utilizacion a titulo de agente inmunoestimulante y composiciones farmaceuticas que lo contienen.
IN170289B (es)
JPS57175101A (en) Killing agent composition for furniture treatment
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
NO922642D0 (no) Oktadecyl-(2-(n-metylpiperidino)-etyl)-fosfat og fremgangsmaate til dets fremstilling
IT8221801A0 (it) Derivati di 1, 2, 3,4-tetraidronaftalene, procedimentodi preparazione e relative composizioni farmaceutiche.
PT94011A (pt) Processo para a preparacao de 8 alfa- acilamino-ergolinas e de composicoes farmaceuticas que as contem
IE900460L (en) Pharmaceutical composition
IT8921560A0 (it) Procedimento di inertizzazione di residui tossici e nocivi in polvere prodotti da procedimenti di termodistruzione.
GR3005231T3 (es)
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
SE8503513L (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili
IT8920387A0 (it) Derivati n dialchilaminoetilbenzamidici fluorurati, loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 288382

Country of ref document: ES